Edition:
India

DelMar Pharmaceuticals Inc (DMPI.OQ)

DMPI.OQ on NASDAQ Stock Exchange Capital Market

0.70USD
22 Jun 2018
Change (% chg)

$-0.05 (-6.98%)
Prev Close
$0.75
Open
$0.75
Day's High
$0.76
Day's Low
$0.66
Volume
182,132
Avg. Vol
44,966
52-wk High
$2.83
52-wk Low
$0.66

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.131
Dec 0.00 -0.143
Sep 0.00 -0.177
FY 2017 Jun '17 0.00 -0.195
Mar '17 0.00 -0.180
Dec 0.00 -0.130
Sep 0.00 -0.230
FY 2016 Jun '16 0.00 -0.333
Mar '16 0.00 -0.103
Dec 0.00 -0.241
Sep 0.00 -0.153
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Earnings (per share)
Quarter Ending Dec-18 1 -0.07 -0.07 -0.07 --
Quarter Ending Mar-18 1 -0.10 -0.10 -0.10 --
Year Ending Jun-18 1 -0.54 -0.54 -0.54 -0.76
Year Ending Jun-19 1 -0.30 -0.30 -0.30 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 8.65 20.18
P/E High - Last 5 Yrs. -- 18.89 28.80
P/E Low - Last 5 Yrs. -- 4.81 11.60
Beta 0.80 1.09 1.47
Price to Sales (TTM) -- 7.92 5.97
Price to Book (MRQ) -- 17.94 2.77
Price to Tangible Book (MRQ) 15.80 20.46 2.91
Price to Cash Flow (TTM) -- 5.05 25.65
% Owned Institutions 8.07 0.65 0.84

Dividends

  Company industry sector
Dividend Yield -- 2.51 1.98
Dividend Yield - 5 Year Avg -- 3.27 2.07
Dividend 5 Year Growth Rate -- 7.43 21.87
Payout Ratio(TTM) -- 19.57 18.89

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 34.46 16.34
Sales (TTM) vs TTM 1 Yr. Ago -- 24.31 11.34
Sales - 5 Yr. Growth Rate -- 24.23 14.09
EPS (MRQ) vs Qtr. 1 Yr. Ago -74.41 132.88 36.56
EPS (TTM) vs TTM 1 Yr. Ago -61.36 -- --
EPS - 5 Yr. Growth Rate -- -3.20 10.48
Capital Spending - 5 Yr. Growth Rate -- 32.47 19.50

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.25 0.05
Current Ratio (MRQ) 2.27 21.45 2.05
LT Debt to Equity (MRQ) 0.00 30.31 31.72
Total Debt to Equity (MRQ) 0.00 35.54 71.30
Interest Coverage (TTM) -16.16 7.12 8.94

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 45.16 3.52
Gross Margin - 5 Yr. Avg. -- 44.84 3.37
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 38.59 48.22
Operating Margin (TTM) -- 190.55 35.97
Operating Margin - 5 Yr. Avg. -- 97.38 40.78
Pre-Tax Margin (TTM) -- 190.79 36.50
Pre-Tax Margin - 5 Yr. Avg. -- 96.00 41.24
Net Profit Margin (TTM) -- 189.61 29.17
Net Profit Margin - 5 Yr. Avg. -- 95.19 32.62
Effective Tax Rate (TTM) -- 4.04 21.06
Effective Tax Rate - 5 Yr. Avg. -- 3.59 20.98

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 99,827,127 57,730,828
Net Income/Employee (TTM) -2,234,290 121,556,449 20,182,119
Receivable Turnover (TTM) -- 16.66 8,547.16
Inventory Turnover (TTM) -- 5.26 0.96
Asset Turnover (TTM) 0.00 0.19 0.02

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -511.25 11.69 2.60
Return on Assets - 5 Yr. Avg. -- 5.00 2.85
Return on Investment (TTM) -992.44 16.01 0.48
Return on Investment - 5 Yr. Avg. -- 8.41 0.52
Return on Equity (TTM) -- 19.39 15.39
Return on Equity - 5 Yr. Avg. -- 8.18 19.96
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -77.23 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for DelMar Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 15.70%
# of Holders: 16
Total Shares Held: 3,456,985
3 Mo. Net Change: 138,065
# New Positions: 5
# Closed Positions: 1
# Increased Positions: 10
# Reduced Positions: 1
# Net Buyers: 9
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.